Primary Chemotherapy in the Treatment of Breast Cancer: The University of Texas M. D. Anderson Cancer Center Experience
- 1 October 2002
- journal article
- review article
- Published by Elsevier BV in Clinical Breast Cancer
- Vol. 3, S63-S68
- https://doi.org/10.3816/cbc.2002.s.014
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Continuous low-dose anti-angiogenic/metronomic chemotherapy: from the research laboratory into the oncologyclinicAnnals Of Oncology, 2002
- Preoperative Chemotherapy in Patients With Operable Breast Cancer: Nine-Year Results From National Surgical Adjuvant Breast and Bowel Project B-18JNCI Monographs, 2001
- Metronomic scheduling: the future of chemotherapy?The Lancet Oncology, 2001
- Prospective Evaluation of Paclitaxel Versus Combination Chemotherapy With Fluorouracil, Doxorubicin, and Cyclophosphamide as Neoadjuvant Therapy in Patients With Operable Breast CancerJournal of Clinical Oncology, 1999
- Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant ChemotherapyJournal of Clinical Oncology, 1999
- Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer.Annals of Surgical Oncology, 1998
- Locally Advanced Breast CancerThe Oncologist, 1996
- Primary chemotherapy in surgically resectable breast cancerCA: A Cancer Journal for Clinicians, 1995
- Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapyCancer, 1988
- Multimodal treatment of locoregionally advanced breast cancerCancer, 1983